Clinical Trial Update: A Phase I/II Study Afatinib/Carboplatin/Paclitaxel Induction Chemotherapy In HPV-Negative HNSCC. [Phase 1, Phase 2]

View source ↗

Summary

A Phase I/II trial evaluating induction chemotherapy with afatinib, carboplatin, and paclitaxel for HPV-negative head and neck squamous cell carcinoma has termi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• Afatinib (afatinib)
• CARBOPLATIN (Carboplatin)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Squamous Cell Carcinoma of the Head and Neck | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2018-07-26